Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXP7WU
|
||||
Drug Name |
N-(2,4-difluorobenzyl)-N-((4-(4-cyanobenzyl)-5-methyl-4H-1,2,4-triazol-3-yl)methyl)quinoline-2-carboxamide
|
||||
Synonyms |
CHEMBL371435
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H22F2N6O
|
||||
Canonical SMILES |
Cc1nnc(CN(Cc2ccc(F)cc2F)C(=O)c3ccc4ccccc4n3)n1Cc5ccc(cc5)C#N
|
||||
InChI |
InChI=1S/C29H22F2N6O/c1-19-34-35-28(37(19)16-21-8-6-20(15-32)7-9-21)18-36(17-23-10-12-24(30)14-25(23)31)29(38)27-13-11-22-4-2-3-5-26(22)33-27/h2-14H,16-18H2,1H3
|
||||
InChIKey |
FLBYMAWUXCWVAF-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.